PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-γ (PPAR-γ) INHIBITS NADPH OXIDASE ACTIVATION UPON ISCHEMIC INSULT

被引：0
|
作者：
Lin, T. N. [1 ]
Wu, J. S. [1 ]
Tsai, H. D. [1 ]
Cheung, W. M. [1 ]
机构：
[1] Acad Sinica, IBMS, Taipei, Taiwan
来源：
JOURNAL OF NEUROCHEMISTRY | 2011年 / 118卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
TU07-12
引用
收藏
页码：154 / 155
页数：2
相关论文
共 50 条
  • [21] Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) and Neurodegenerative Disorders
    Yu-Chang Chen
    Jui-Sheng Wu
    Hsin-Da Tsai
    Chien-Yu Huang
    Jin-Jer Chen
    Grace Y. Sun
    Teng-Nan Lin
    Molecular Neurobiology, 2012, 46 : 114 - 124
  • [22] Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) and Neurodegenerative Disorders
    Chen, Yu-Chang
    Wu, Jui-Sheng
    Tsai, Hsin-Da
    Huang, Chien-Yu
    Chen, Jin-Jer
    Sun, Grace Y.
    Lin, Teng-Nan
    MOLECULAR NEUROBIOLOGY, 2012, 46 (01) : 114 - 124
  • [23] Targeting Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) for Cancer Chemoprevention
    Peters J.M.
    Yao P.-L.
    Gonzalez F.J.
    Current Pharmacology Reports, 2015, 1 (2) : 121 - 128
  • [24] Flexible ligand recognition of peroxisome proliferator-activated receptor-γ (PPARγ)
    Yamagishi, Kenji
    Yamamoto, Keiko
    Mochizuki, Yuji
    Nakano, Tatsuya
    Yamada, Sachiko
    Tokiwa, Hiroaki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (11) : 3344 - 3347
  • [25] Antihypertensive effects of peroxisome proliferator-activated receptor-β/δ activation
    Toral, Marta
    Romero, Miguel
    Perez-Vizcaino, Francisco
    Duarte, Juan
    Jimenez, Rosario
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2017, 312 (02): : H189 - H200
  • [26] Increased expression of peroxisome proliferator-activated receptor (PPAR)-α, and PPAR-γ in human atherosclerosis
    Sueyoshi, Sumihisa
    Mitsumata, Masako
    Kusumi, Yoshiaki
    Niihashi, Mari
    Esumi, Mariko
    Yamada, Tsutomu
    Sakurai, Isamu
    PATHOLOGY RESEARCH AND PRACTICE, 2010, 206 (07) : 429 - 438
  • [27] Targeting Peroxisome Proliferator-Activated Receptor- ? (PPAR- ? ) to reduce paclitaxel-induced peripheral neuropathy
    Caillaud, Martial
    Patel, Nipa H.
    White, Alyssa
    Wood, Mackinsey
    Contreras, Katherine M.
    Toma, Wisam
    Alkhlaif, Yasmin
    Roberts, Jane L.
    Tran, Tammy H.
    Jackson, Asti B.
    Poklis, Justin
    Gewirtz, David A.
    Damaj, M. Imad
    BRAIN BEHAVIOR AND IMMUNITY, 2021, 93 : 172 - 185
  • [28] Sex dimorphic actions of rosiglitazone in generalised peroxisome proliferator-activated receptor-γ (PPAR-γ)-deficient mice
    Duan, S. Z.
    Usher, M. G.
    Foley, E. L.
    Milstone, D. S.
    Brosius, F. C., III
    Mortensen, R. M.
    DIABETOLOGIA, 2010, 53 (07) : 1493 - 1505
  • [29] Sex dimorphic actions of rosiglitazone in generalised peroxisome proliferator-activated receptor-γ (PPAR-γ)-deficient mice
    S. Z. Duan
    M. G. Usher
    E. L. Foley
    D. S. Milstone
    F. C. Brosius
    R. M. Mortensen
    Diabetologia, 2010, 53 : 1493 - 1505
  • [30] Inflammation in diabetes mellitus:: Role of peroxisome proliferator-activated receptor-α and peroxisome proliferator-activated receptor-γ agonists
    Libby, Peter
    Plutzky, Jorge
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (4A): : 27B - 40B
12345